Meta Pixel

News and Announcements

Alcidion Group (ASX: ALC) Acquires MKM Health & Patientrack

  • Published April 25, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Alcidion Group Limited is a software business specialising in health informatics.
  • Alcidion acquired MKM Health and Patientrack, two of the largest information technology businesses in the healthcare sector.
  • The complete integration is aimed to be achieved by June 2018.

Alcidion Group Limited is a health informatics software company that has made an acquisition of MKM Health and Patientrack. MKM Health is an information technology business that offers products and services digitally to healthcare suppliers in Australia and New Zealand. MKM Health collaborated with Patientrack to be Patientrack’s information technology service provider and sole distributor. Patientrack is a United Kingdom-orientated healthcare software programme
that is aimed at refining patient security.

The acquisition will allow for a new network of technology to be available within the healthcare sector and will provide Alcidion with a larger client base and greater impression globally. Further, the acquisition will allow the company to expand its technology, information technology sales, its products, and its services. Therefore, this will allow Alcidion to increase its profit.

Ms Kate Quirke will be assigned the role of Chief Executive of the newly expanded Alcidion Federation and will be the Executive Director. The current CEO of Alcidion, Ray Blight, will become the Executive Chairman of the enlarged group. The expansion of Alcidion is part of its strategic basis for international recognition. The aim is to improve the proficiency of the
integrated healthcare sector from a business as well as clinical point of view. Completion of the merger between these healthcare information technology companies is expected by the end of June 2018.

 

About Alcidion Group Ltd (ASX: ALC)

Alcidion Corporation is an ASX-listed leading health informatics company founded by the former CEO of the SA Health Department and Professor Malcolm Pradhan.

Request Information

Capital Insights
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t

The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.

Capital Insights
Following the Billions: Where the Hyperscalers are Betting on the Future

The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.

Join over 45,000+ sophisticated investors

Join Now